An association study of sodium-lithium countertransport activity with glutathione S transferase (GST) T1 and GST M1 null polymorphisms in Greek dyslipidaemic patients and controls

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 3, 2008, Pages 306-310

  Goulas, Antonis ^a   Kosmidou, Maria ^b   Hatzitolios, Apostolos I ^b   Raikos, Nikos ^a   Molyva, Dimitra ^a   Savopoulos, Christos ^b   Giannopoulos, Sotiris ^c   Fidani, Liana ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Dyslipidaemia; Gene polymorphisms; Glutathione S transferase; Hypertension; Sodium lithium countertransport

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; LITHIUM; SODIUM;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD PRESSURE; CELL ISOLATION; CONTROLLED STUDY; COVARIANCE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ERYTHROCYTE; FEMALE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; GREECE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEMBRANE TRANSPORT; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SMOKING; SODIUM LITHIUM COUNTERTRANSPORT; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TRANSPORT KINETICS;

ANTIPORTERS; CASE-CONTROL STUDIES; DYSLIPIDEMIAS; ERYTHROCYTES; FEMALE; GLUTATHIONE TRANSFERASE; GREECE; HUMANS; HYPERTENSION; ION TRANSPORT; LITHIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN BINDING; SODIUM;

EID: 39849098959     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.065     Document Type: Article

References (24)

1. West IC, Rutherford PA, Thomas TH. Sodium-lithium countertransport: physiology and function. J Hypertens 1998;16:3-13.
2. Giordano M, Castellino P, Solini A, Canessa ML, De-Fronzo RA. Na+/Li+, and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and hypertensive treatment. Metabolism 1997;46:1316-23.
3. Carr SJ, Thomas TH, Laker MF, Wilkinson R. Elevated sodium-lithium countertransport: a familial marker of hyperlipidaemia and hypertension? J Hypertens 1990;8:139-46.
4. Zerbini G, Maestroni A, Breviario D, Mangili R, Casari G. Alternative splicing of NHE-1 mediates Na-Li counter-transport and associates with activity rate. Diabetes 2003;52:1511-8.
5. Schork NJ, Gardner JP, Zhang L, Fallin D, Thiel B, Jakubowski H, et al. Genomic association/linkage of sodium lithium countertransport in CEPH pedigrees. Hypertension 2002;40:619-28.
6. Hasstedt SJ, Camp NJ, Hopkins PN, Coon H, McKinney JT, Cawthon RM, et al. Model-fitting and linkage analysis of sodium-lithium countertransport. Eur J Hum Genet 2004;12:1055-61.
7. Morrison AC, Boerwinkle E, Turner ST, Ferrell RE. Genome-wide linkage study of erythrocyte sodium-lithium countertransport. Am J Hypertens 2005;18:653-6.
8. Mead P, Wilkinson R, Thomas TH. Thiol protein defect in sodium-lithium countertransport in subset of essential hypertension. Hypertension 1999;34:1275-80.
9. Canessa M, Adragna N, Solomon H, Connolly T, Tosteson D. Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 1980;302:772-6.
10. Joseph T, Chacko P, Wesley R, Jayaprakash PG, James FV, Pillai MR. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection. Gynecol Oncol 2006;101:411-7.
11. Dirksen U, Moghadam KA, Mambetova C, Esser C, Fuhrer M, Burdach S. Glutathione S transferase theta 1 gene (GSTT1) null genotype is associated with an increased risk for acquired aplastic anemia in children. Pediatr Res 2004;55:466-71.
12. Hunt SC, Williams RR, Smith JB, Ash KO. Associations of three erythrocyte cation transport systems with plasma lipids in Utah subjects. Hypertension 1986;8:30-6.
13. + countertransport kinetics by two types of thiol group. Biochim Biophys Acta 1995;1235:317-22.
14. Mead P, Wilkinson R, Thomas TH. Thiol protein defect in sodium-lithium countertransport in subset of essential hypertension. Hypertension 1999;34:1275-80.
15. Watkins SL, West IC, Wilkinson R, Thomas TH. Abnormal thiol reactivity of tropomyosin in essential hypertensives and its association with abnormal sodium-lithium countertransport kinetics. J Hypertens 2001;19:485-93.
16. Barford D. The role of cysteine residues as redox-sensitive regulatory switches. Curr Opin Struct Biol 2004;14:679-86.
17. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury. Part II: animal and human studies. Circulation 2003;108:2034-40.
18. Kontush A, Chapman MJ. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 2006;58:342-74.
19. Kashyap MK, Yadav V, Sherawat BS, Jain S, Kumari S, Khullar M, et al. Different antioxidant status, total antioxidant power and free radical in essential hypertension. Mol Cell Biochem 2005;277:89-99.
20. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004;122:339-52.
21. Marinho C, Alho I, Arduino D, Falcao LM, Bras-Nogueira J, Bicho M. GST M1/T1 and MTHFR polymorphisms as risk factors for hypertension. Biochem Biophys Res Commun 2007;353:344-50.
22. Tew MB, Reveille JD, Arnett FC, Friedman AW, McNearney T, Fischbach M, et al. Glutathione S-transferase genotypes in systemic sclerosis and their association with clinical manifestations in early disease. Genes Immun 2001;2:236-8.
23. Palmer CA, Young V, Ho M, Doney A, Belch JJ. Association of common variation of in glutathione S-transferase genes with premature development of cardiovascular disease in patients with systemic sclerosis. Arthrit Rheumat 2003;48:854-5.
24. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271-6.